These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 24310603)

  • 1. Tardive dyskinesia: therapeutic options for an increasingly common disorder.
    Cloud LJ; Zutshi D; Factor SA
    Neurotherapeutics; 2014 Jan; 11(1):166-76. PubMed ID: 24310603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tardive dyskinesia: clinical presentation and treatment.
    van Harten PN; Tenback DE
    Int Rev Neurobiol; 2011; 98():187-210. PubMed ID: 21907088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-antipsychotic catecholaminergic drugs for antipsychotic-induced tardive dyskinesia.
    El-Sayeh HG; Rathbone J; Soares-Weiser K; Bergman H
    Cochrane Database Syst Rev; 2018 Jan; 1(1):CD000458. PubMed ID: 29342497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of tardive syndromes].
    Horváth K; Aschermann Z; Komoly S; Kovács A; Kovács N
    Psychiatr Hung; 2014; 29(2):214-24. PubMed ID: 25041749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and management of tardive dyskinesia: A case series and literature review.
    Khouzam HR
    Postgrad Med; 2015; 127(7):726-37. PubMed ID: 26216578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prevention and treatment of tardive dyskinesia caused by antipsychotic drugs].
    Seigneurie AS; Sauvanaud F; Limosin F
    Encephale; 2016 Jun; 42(3):248-54. PubMed ID: 26922134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of Tardive Syndrome: Medications and Surgical Treatments.
    Factor SA
    Neurotherapeutics; 2020 Oct; 17(4):1694-1712. PubMed ID: 32720245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of Tardive Dyskinesia: A General Overview with Focus on the Vesicular Monoamine Transporter 2 Inhibitors.
    Niemann N; Jankovic J
    Drugs; 2018 Apr; 78(5):525-541. PubMed ID: 29484607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Forgotten but not gone: new developments in the understanding and treatment of tardive dyskinesia.
    Meyer JM
    CNS Spectr; 2016 Dec; 21(S1):13-24. PubMed ID: 28044943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Tardive dyskinesia].
    Zalyalova ZA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2023; 123(7):25-31. PubMed ID: 37490662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-neuroleptic catecholaminergic drugs for neuroleptic-induced tardive dyskinesia.
    El-Sayeh HG; Lyra da Silva JP; Rathbone J; Soares-Weiser K
    Cochrane Database Syst Rev; 2006 Jan; (1):CD000458. PubMed ID: 16437424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tardive dyskinesia (syndrome): Current concept and modern approaches to its management.
    Lerner PP; Miodownik C; Lerner V
    Psychiatry Clin Neurosci; 2015 Jun; 69(6):321-34. PubMed ID: 25556809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Miscellaneous treatments for antipsychotic-induced tardive dyskinesia.
    Soares-Weiser K; Rathbone J; Ogawa Y; Shinohara K; Bergman H
    Cochrane Database Syst Rev; 2018 Mar; 3(3):CD000208. PubMed ID: 29552749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of Tardive Dyskinesia.
    Bashir HH; Jankovic J
    Neurol Clin; 2020 May; 38(2):379-396. PubMed ID: 32279716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroleptic reduction and/or cessation and neuroleptics as specific treatments for tardive dyskinesia.
    McGrath JJ; Soares KV
    Cochrane Database Syst Rev; 2000; (2):CD000459. PubMed ID: 10796546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological treatment of tardive dyskinesia: recent developments.
    Caroff SN; Campbell EC; Carroll B
    Expert Rev Neurother; 2017 Sep; 17(9):871-881. PubMed ID: 28727483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deep brain stimulation for intractable tardive dystonia: Literature overview.
    Sobstyl M; Ząbek M
    Neurol Neurochir Pol; 2016; 50(2):114-22. PubMed ID: 26969568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case of tardive dyskinesia in the last weeks of life.
    Yehl JL; Sheyner I; Fasnacht KS; Stewart JT
    J Pain Palliat Care Pharmacother; 2015 Jun; 29(2):144-7. PubMed ID: 26095485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Late-Onset Dyskinesia Occurring During Antipsychotic Treatment for Schizophrenia: Management of Tardive Dyskinesia Based on the Latest Knowledge].
    Sakata M; Ito H
    Brain Nerve; 2022 May; 74(5):571-574. PubMed ID: 35589649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antipsychotic-induced Tardive dyskinesia: from biological basis to clinical management.
    Salem H; Pigott T; Zhang XY; Zeni CP; Teixeira AL
    Expert Rev Neurother; 2017 Sep; 17(9):883-894. PubMed ID: 28750568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.